AGK (Acylglycerol Kinase)

Mitochondrial membrane protein with kinase activity; mutations cause Sengers syndrome and are linked to cataract and cardiomyopathy.

Gene Information Card

Symbol AGK
Full Name Acylglycerol Kinase
Gene Type Protein coding
Chromosomal Location 7q34
NCBI Gene ID 55750 ncbi.nlm.nih.gov/gene/55750
Ensembl ID ENSG00000106546
UniProt ID Q53H12
OMIM ID 610345
HGNC ID 32569
Aliases MUL, FLJ10842, HsT18881

Description

The AGK gene encodes acylglycerol kinase, a mitochondrial membrane protein that catalyzes the phosphorylation of monoacylglycerol and diacylglycerol to form lysophosphatidic acid and phosphatidic acid, respectively. This enzyme is essential for mitochondrial lipid metabolism and import of mitochondrial carrier proteins. Mutations in AGK cause Sengers syndrome, characterized by congenital cataract, hypertrophic cardiomyopathy, skeletal myopathy, and lactic acidosis. AGK is also implicated in certain cancers and metabolic disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Sengers syndrome Loss-of-function mutations in AGK impair mitochondrial acylglycerol kinase activity, leading to defective mitochondrial carrier protein import and energy metabolism. ClinVar, OMIM
Cataract (congenital) AGK mutations disrupt lens mitochondrial function, contributing to cataract formation. ClinVar, OMIM
Cardiomyopathy (hypertrophic) Defective mitochondrial lipid metabolism due to AGK deficiency causes cardiac hypertrophy. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.5 Medium
Skeletal muscle 10.2 Medium
Liver 8.7 Medium
Kidney 7.3 Low
Brain 5.1 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.3 Cervical cancer cell line
HEK293 12.8 Embryonic kidney cell line
HepG2 9.4 Hepatocellular carcinoma cell line
K562 6.7 Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.113A>G (p.Tyr38Cys) Missense Rare Likely loss of function; associated with Sengers syndrome
c.334C>T (p.Arg112*) Nonsense Rare Truncating; loss of function; Sengers syndrome
c.676_677delAG (p.Ser226fs) Frameshift Rare Loss of function; Sengers syndrome
Mutation functional classification

Loss of Function (LOF)

Most AGK mutations are loss-of-function, leading to reduced acylglycerol kinase activity and mitochondrial dysfunction.

Gain of Function (GOF)

No gain-of-function mutations reported in AGK.

Dominant Negative (DN)

No dominant-negative mutations reported in AGK.

Gene Ontology (GO)

• GO:0005739 - mitochondrion • GO:0005524 - ATP binding
• GO:0001727 - lipid kinase activity • GO:0046834 - acylglycerol kinase activity
• GO:0006644 - phospholipid metabolic process • GO:0016020 - membrane

Pathways

Glycerophospholipid metabolism (Reactome: R-HSA-1483206)
Mitochondrial protein import (Reactome: R-HSA-1268020)

Protein Summary

Acylglycerol kinase (AGK) is a 422-amino acid mitochondrial membrane protein with a molecular weight of approximately 47 kDa. It contains a conserved DAGK domain and catalyzes the ATP-dependent phosphorylation of mono- and diacylglycerol. AGK is essential for the assembly of the TIM22 complex, which imports carrier proteins into the mitochondrial inner membrane. Defects in AGK lead to Sengers syndrome and are associated with cataract and cardiomyopathy.

Related Products

Product name Cat.No. Species Gene ID
AGK Knockout HEK293 Cell Line EDJ-KQ12308 Human 55750 Details Get a Quote
NAGK Knockout HEK293 Cell Line EDJ-KQ14365 Human 55577 Details Get a Quote
AGK Knockout A-549 Cell Line EDJ-KQ41139 Human 55750 Details Get a Quote
AGK Knockout HCT 116 Cell Line EDJ-KQ41140 Human 55750 Details Get a Quote
AGK Knockout HeLa Cell Line EDC90512 Human 55750 Details Get a Quote
NAGK Knockout HCT 116 Cell Line EDJ-KQ44501 Human 55577 Details Get a Quote
NAGK Knockout HeLa Cell Line EDJ-KQ44502 Human 55577 Details Get a Quote
NAGK Knockout A-549 Cell Line EDJ-KQ43263 Human 55577 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: